Answer
Yes, palopegteriparatide (Yorvipath) is contraindicated in people with pseudohypoparathyroidism.
Sources for this answer
- Yorvipath 294 micrograms/0.98 mL solution for injection in pre filled penAscendis Pharma UK Limited · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked